Edward J. Shillitoe

Articles in Scholarly Journals [Incomplete List]

  1. The mechanism of exogenous B7.1-enhanced IL-12-mediated complete regression of tumors by a single electroporation delivery
    International Journal of Cancer, vol. 119, no. 9, pp. 2113–2118, 2006
  2. Papillomaviruses as targets for cancer gene therapy
    Cancer Gene Therapy, vol. 13, no. 5, Article ID 7700926, 5 pages, 2006
  3. Analysis of apoptosis-associated genes and pathways in oral cancer cells
    Journal of Oral Pathology and Medicine, vol. 35, no. 3, pp. 146–154, 2006
  4. Factors That Limit the Effectiveness of Herpes Simplex Virus Type 1 for Treatment of Oral Cancer in Mice
    Clinical Cancer Research, vol. 11, no. 8, pp. 3109–3116, 2005
  5. Proteome-wide analysis of head and neck squamous cell carcinomas using laser-capture microdissection and tandem mass spectrometry
    Oral Oncology, vol. 41, no. 2, pp. 183–199, 2005
  6. Detection of plasminogen activators in oral cancer by laser capture microdissection combined with zymography
    Oral Oncology, vol. 40, no. 10, pp. 1026–1032, 2004
  7. Gene discovery in oral squamous cell carcinoma through the Head and Neck Cancer Genome Anatomy Project: confirmation by microarray analysis
    Oral Oncology, vol. 39, no. 3, pp. 248–258, 2003
  8. Clinical and pathological features of the murine AT-84 orthotopic model of oral cancer
    Oral Diseases, vol. 9, no. 6, pp. 305–312, 2003
  9. Effect of herpes simplex virus type-1 on growth of oral cancer in an immunocompetent, orthotopic mouse model
    Oral Oncology, vol. 38, no. 4, pp. 349–356, 2002
  10. The unexplained survival of cells in oral cancer: what is the role of p53?
    Journal of Oral Pathology and Medicine, vol. 31, no. 3, pp. 125–133, 2002
  11. Strength and specificity of different gene promoters in oral cancer cells
    Oral Oncology, vol. 36, no. 2, pp. 214–220, 2000
  12. Genome-wide analysis of oral cancer—early results from the Cancer Genome Anatomy Project
    Oral Oncology, vol. 36, no. 1, pp. 8–16, 2000
  13. Editorial
    Oral Oncology, vol. 36, no. 1, pp. 1–2, 2000
  14. Gene expression profiles in squamous cell carcinomas of the oral cavity: use of laser capture microdissection for the construction and analysis of stage-specific cDNA libraries
    Oral Oncology, vol. 36, no. 5, pp. 474–483, 2000
  15. Antisense-mediated inhibition of the bcl-2 gene induces apoptosis in human malignant glioma
    Surgical Neurology, vol. 53, no. 4, pp. 360–369, 2000
  16. Establishment of a human polyclonal oral epithelial cell line1
    Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology & Endodontics, vol. 90, no. 3, pp. 340–347, 2000
  17. Effects of herpes simplex virus on human oral cancer cells, and potential use of mutant viruses in therapy of oral cancer
    Oral Oncology, vol. 35, no. 3, pp. 326–332, 1999
  18. Gene therapy for oral cancer: recent progress in research
    Oral Oncology, vol. 34, no. 3, pp. 157–160, 1998
  19. The effect on cell phenotype of the mutagenic peptide of herpes simplex virus type-1
    European Journal of Cancer. Part B: Oral Oncology, vol. 31, no. 4, pp. 267–274, 1995
  20. The antiviral spectrum of Listerine antiseptic†, ‡
    Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology, vol. 79, no. 4, pp. 442–448, 1995
  21. Expression of the mutagenic peptide of herpes simplex virus type 1 in virus-infected cells
    Virus Research, vol. 34, no. 2, pp. 97–114, 1994
  22. Gene therapy—Its potential in the management of oral cancer
    European Journal of Cancer. Part B: Oral Oncology, vol. 30, no. 3, pp. 143–154, 1994
  23. Functions and proteins of herpes simplex virus type-1 that are involved in raising the mutation frequency of infected cells
    Virus Research, vol. 27, no. 3, pp. 239–251, 1993
  24. Antibody to a mutagenic peptide of herpes simplex virus in young adult patients with cancer of the head and neck
    Oral Surgery, Oral Medicine, Oral Pathology, vol. 75, no. 5, pp. 610–614, 1993
  25. Analysis of human papillomavirus DNA in oral squamous cell carcinomas
    Journal of Oral Pathology and Medicine, vol. 22, no. 3, pp. 101–108, 1993
  26. Inhibition of the Transformed Phenotype of Carcinoma Cells That Contain Human Papillomavirus
    Annals of the New York Academy of Sciences, vol. 660, no. 1, pp. 286–287, 1992
  27. Prevalence of Epstein-Barr virus and human papillomavirus in oral mucosa of HIV-Infected patients
    Journal of Oral Pathology and Medicine, vol. 21, no. 4, pp. 164–170, 1992
  28. Analysis of complex mutations induced in cells by herpes simplex virus type-1
    Virology, vol. 181, no. 2, pp. 620–629, 1991
  29. DNA sequence of mutations induced in cells by herpes simplex virus type-1
    Virology, vol. 178, no. 1, pp. 180–188, 1990
  30. Cytogenetic characterization of 20 lymphoblastoid lines derived from human individuals differing in bleomycin sensitivity
    In Vitro Cellular & Developmental Biology, vol. 26, no. 1, pp. 80–84, 1990
  31. Oral melanotic macules in patients infected with human immunodeficiency virus
    Oral Surgery, Oral Medicine, Oral Pathology, vol. 70, no. 6, pp. 748–755, 1990
  32. Five-year survival of patients with oral cancer and its association with antibody to herpes simplex virus
    Cancer, vol. 58, no. 10, pp. 2256–2259, 1986
  33. Induction of mutations in bacteria by a fragment of DNA from herpes simplex virus type 1
    Virus Research, vol. 6, no. 2, pp. 181–191, 1986
  34. Immunoglobulin class of antibody to herpes simplex virus in patients with oral cancer
    Cancer, vol. 51, no. 1, pp. 65–71, 1983
  35. Neutralizing antibody to Herpes simplex virus type 1 in patients with oral cancer
    Cancer, vol. 49, no. 11, pp. 2315–2320, 1982
  36. Antibody to cytomegalovirus in patients with sjögren's syndrome. As determined by an enzyme-linked immunosorbent assay
    Arthritis & Rheumatism, vol. 25, no. 3, pp. 260–265, 1982
  37. Decline in specificity of the ELISA due to storage of serum, and its recovery by adsorption with kaolin
    Journal of Virological Methods, vol. 4, no. 4-5, pp. 241–248, 1982
  38. Oral cancer and herpes simplex virus—A review
    Oral Surgery, Oral Medicine, Oral Pathology, vol. 48, no. 3, pp. 216–224, 1979
  39. Sequential Changes in T and B Lymphocyte Responses to Herpes Simplex Virus in Man
    Scandinavian Journal of Immunology, vol. 7, no. 5, pp. 357–366, 1978
  40. IMMUNOLOGICAL BASIS FOR LATENCY, RECURRENCES, AND PUTATIVE ONCOGENICITY OF HERPES SIMPLEX VIRUS
    The Lancet, vol. 306, no. 7924, pp. 60–62, 1975
  41. IMMUNOLOGICAL FEATURES OF WEGENER'S GRANULOMATOSIS
    The Lancet, vol. 303, no. 7863, p. 929, 1974
  42. IMMUNOLOGICAL FEATURES OF WEGENER'S GRANULOMATOSIS
    The Lancet, vol. 303, no. 7852, pp. 281–284, 1974
  43. WEGENER'S GRANULOMATOSIS
    The Lancet, vol. 303, no. 7861, p. 805, 1974
  44. Immunoglobulins and complement in crevicular fluid, serum and saliva in man
    Archives of Oral Biology, vol. 17, no. 2, pp. 241–247, 1972